Dugan Margaret

SEC Form 4 insider trading activity

Dugan Margaret has filed 4 SEC Form 4 filings (4 transaction rows) across 3 companies, including ONC, WHWK, SDGR, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Jun 15, 2026.

On the most recent filing, Dugan Margaret is listed as Director at BeOne Medicines Ltd. Inside the rolling window, Dugan Margaret reported no open-market purchases and 2 open-market sales totaling $95K in ONC and SDGR. The largest disclosed transaction in the window is a sale of 212 ONC shares on May 22, 2026, worth $66K.

Companies traded

Other insiders at ONC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$95K

reported sales (SEC code S)

Companies

3

in the rolling window

Source
ONCSale$66KMay 27SEC ↗
SDGRSale$29KOct 17SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Dugan Margaret made?

Dugan Margaret has filed 4 SEC Form 4 filings (4 transaction rows) across 3 companies, including ONC, WHWK, SDGR since 2025.

Which companies does Dugan Margaret trade?

Dugan Margaret has filed SEC Form 4 disclosures for 3 companies, including ONC, WHWK, SDGR.

When was Dugan Margaret's most recent SEC Form 4 filing?

Dugan Margaret's most recent SEC Form 4 filing on Tracefour is dated Jun 15, 2026.

What is Dugan Margaret's total buy and sell value in the current window?

Inside the rolling retention window, Dugan Margaret bought $0 and sold $95K based on SEC Form 4 filings.

What was Dugan Margaret's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 212 ONC shares on 2026-05-22, worth $66K, per SEC Form 4 filings.